ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,275Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 617

$628K Total Retail Price of All Prescriptions

Rank: 41 out of 617

485 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 585 509 1 1
WARFARIN SODIUM 404 372 2 7
HYDROCODONE-ACETAMINOPHEN 388 238 S3 3 8
AMLODIPINE BESYLATE 360 336 4 6
OMEPRAZOLE 350 265 5 3
METOPROLOL SUCCINATE 327 273 6 12
SIMVASTATIN 297 272 7 2
POTASSIUM CHLORIDE 284 250 8 10
FUROSEMIDE 266 254 9 4
LISINOPRIL 261 226 10 5
METOPROLOL TARTRATE 259 224 11 11
TAMSULOSIN HCL 209 188 12 26
RANITIDINE HCL 203 135 13 40
SERTRALINE HCL 178 175 14 20
ISOSORBIDE MONONITRATE ER 176 167 15 52
HYDROCHLOROTHIAZIDE 174 141 16 13
ALLOPURINOL 168 168 17 27
GLIMEPIRIDE 166 119 18 33
ZOLPIDEM TARTRATE 163 108 19 23
METFORMIN HCL 162 146 20 9
MELOXICAM 159 135 21 24
PANTOPRAZOLE SODIUM 144 108 22 37
TRIAMTERENE-HCTZ 134 103 23 47
FENTANYL 134 127 S2 23 45
CARVEDILOL 133 133 25 19
ATENOLOL 132 120 26 17
TRAMADOL HCL 127 91 27 15
LOSARTAN POTASSIUM 126 120 28 22
GABAPENTIN 125 106 29 16
OXYCODONE HCL 108 39 S2 30 130
DONEPEZIL HCL 105 105 31 30
ATORVASTATIN CALCIUM 105 75 31 14
PRAVASTATIN SODIUM 105 99 31 21
CYMBALTA 100 48 34 49
ROPINIROLE HCL 96 79 35 66
ALENDRONATE SODIUM 96 96 35 25
SINGULAIR 90 24 37 106
POLYETHYLENE GLYCOL 3350 90 88 37 32
CRESTOR 85 77 39 28
MIRTAZAPINE 84 84 40 50
CEPHALEXIN 83 73 41 68
PREDNISONE 83 75 41 31
LOSARTAN-HYDROCHLOROTHIAZIDE 79 79 43 46
FAMOTIDINE 75 75 44 54
LEVOXYL 73 73 45 209
CLOPIDOGREL 72 63 46 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 54 46 91
NAPROXEN 70 55 48 101
LYRICA 70 55 48 92
NEXIUM 69 65 50 43
AMLODIPINE BESYLATE-BENAZEPRIL 69 69 50 80
CIPROFLOXACIN HCL 66 58 52 60
TRICOR 65 65 53 83
OXYCONTIN 64 21 S2 54 133
MONTELUKAST SODIUM 64 20 54 192
SPIRONOLACTONE 64 62 54 42
CELEBREX 64 64 54 63
DIOVAN 64 46 54 41
QUETIAPINE FUMARATE 63 59 59 78
AMIODARONE HCL 61 60 60 129
OXYBUTYNIN CHLORIDE ER 61 57 60 114
CARBIDOPA-LEVODOPA 61 61 60 69
CITALOPRAM HBR 60 59 63 18
PLAVIX 60 53 63 86
RAMIPRIL 59 48 65 67
PHENYTOIN SODIUM EXTENDED 59 59 65 121
AMITRIPTYLINE HCL 58 42 R 67 56
TRAZODONE HCL 57 22 68 51
MORPHINE SULFATE ER 56 0 S2 69 128
DOXYCYCLINE HYCLATE 54 47 70 113
BYSTOLIC 54 54 70 64
BENAZEPRIL HCL 54 54 70 44
TRIAMCINOLONE ACETONIDE 53 43 73 102
FLUTICASONE PROPIONATE 52 46 74 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 52 74 29
DILTIAZEM ER 52 52 74 81
AGGRENOX 51 51 77 155
PROMETHAZINE HCL 50 0 R 78 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.